Comorbidity Detection Promotes Improved Diagnosis And Treatment
Editors :
André Barciela Veras & Jeffrey P. Kahn
A counterintuitive and novel approach to the long-sought goal of subtyping schizophrenia and other psychotic disorders emerges from ongoing research. Five psychosis associated anxiety and depressive subtypes each help define five corresponding psy ...view more
A counterintuitive and novel approach to the long-sought goal of subtyping schizophrenia and other psychotic disorders emerges from ongoing research. Five psychosis associated anxiety and depressive subtypes each help define five corresponding psychosis diagnoses, their fixed false beliefs, and most importantly, their treatments.
These anxiety and depressive comorbidities have long been long overlooked as an understandable hodgepodge of distressing symptoms caused by the pain of psychosis. But these five comorbidities usually precede onset of the psychosis, and their treatment can significantly improve outcome. So, maybe, the causation is the other way around: maybe they are among the underlying contributors to schizophrenia and other psychotic disorders.
The chapter authors expertly detail the data supporting this innovative approach. They provide fictional case studies, DSM-5 diagnostic criteria, specific interviewing approaches for the five comorbidities in psychosis patients, and improved treatment options. Other chapters explore psychoses related to substance use, medical illness and medical treatment, as well as other factors that contribute to psychotic disorders.
This first-of-its-kind reference is a valuable clinical, educational, research and training resource for psychiatrists, psychologists, nurses, social workers, neurologists and anyone interested in the care and treatment of someone with a psychotic disorder.
A counterintuitive and novel approach to the long-sought goal of subtyping schizophrenia and other psychotic disorders emerges from ongoing research. Five psychosis associated anxiety and depressive subtypes each help define five corresponding psychosis diagnoses, their fixed false beliefs, and most importantly, their treatments.
These anxiety and depressive comorbidities have long been long overlooked as an understandable hodgepodge of distressing symptoms caused by the pain of psychosis. But these five comorbidities usually precede onset of the psychosis, and their treatment can significantly improve outcome. So, maybe, the causation is the other way around: maybe they are among the underlying contributors to schizophrenia and other psychotic disorders.
The chapter authors expertly detail the data supporting this innovative approach. They provide fictional case studies, DSM-5 diagnostic criteria, specific interviewing approaches for the five comorbidities in psychosis patients, and improved treatment options. Other chapters explore psychoses related to substance use, medical illness and medical treatment, as well as other factors that contribute to psychotic disorders.
This first-of-its-kind reference is a valuable clinical, educational, research and training resource for psychiatrists, psychologists, nurses, social workers, neurologists and anyone interested in the care and treatment of someone with a psychotic disorder.
Key Features
Reflects current research, diagnosis, and treatment options for:
Schizophrenia with Voices and Panic Anxiety
Obsessive-Compulsive Schizophrenia and Obsessive-Compulsive Disorder
Persecutory Delusional Disorder and Social Anxiety
Delusional Depression and Melancholic Depression
Bipolar I Disorder and Atypical Depression
Substance Use Psychoses
Medical Illness and Iatrogenic Psychoses
Covers treatment options and outcomes with medication and psychotherapy.
Includes sample patient interview approaches and/or biological tests for each diagnosis.
Highlights symptoms, quasi-psychotic symptoms and secondary signs of the comorbidities when alone, and when in conjunction with psychosis.
Reviews diagnosis-specific significance and contributory roles of neurotransmitters, hypofrontality, psychological trauma, and genetics.
Enhanced eBook version allows access to entire book contents on most devices. Included free with book purchase, or purchase separately.
Author Information
Edited by André Barciela Veras, MD, PhD, Department of Psychiatry, University of the State of Mato Grosso do Sul, Campo Grande – MS, Brazil and Jeffrey P. Kahn, MD, Weill-Cornell Medical College, New York, New York
"The editors have organized the text around a remarkable concept that five psychoses account for much of functional psychotic disorders. These five psychotic disorders have common causal factors that contribute to psychosis proneness. Three of these psychoses are already well recognized, and all five appear to be associated with a specific anxiety or depressive disorder. All this implies that neuroleptic treatment, when combined with properly specific anxiety and depression treatment, can make patients much better than with neuroleptics alone. Both editors have contributed to the supporting literature, but there is also a fascinating agenda for further research to explore and expand these concepts. When further documented by additional research, these diagnoses and treatments could have effects on psychotic disorder diagnosis and treatment that could be exceptional, if not ground-breaking. This is clearly a book that needs careful attention in a review, and a wide mental health audience." -- Ira D. Glick, M.D., Professor Emeritus of Psychiatry & Behavioral Sciences, Department of Psychiatry, Stanford University School of Medicine
" Anxiety disorders have suffered relative neglect by psychiatry and psychopharmacology over the past several decades. Drs. Veras and Kahn have done the field a great service by putting together a volume that highlights the important overlap of these disorders, not just with mood disorders, but with schizophrenia spectrum illness as well. Psychotic Disorders will serve as a useful reminder of these under-appreciated comorbidities, in the service of more meaningful classification of psychoses and more effective treatment of those suffering from them." -- Edward Silberman, Professor of Psychiatry, Tufts University School of Medicine
https://www.us.elsevierhealth.com/psychotic-disorders-9780323683098.html133439Psychotic Disordershttps://www.us.elsevierhealth.com/media/catalog/product/9/7/9780323683098_3.jpg74.19105.99USDInStock/Medicine/Psychiatry/Medical Students/Psychiatry/Psychiatry Review/Books/Get Free Thirty-Day Access With a Purchase17119246762755255039572138713875145120<P>A counterintuitive and novel approach to the long-sought goal of subtyping schizophrenia and other psychotic disorders emerges from ongoing research. Five psychosis associated anxiety and depressive subtypes each help define five corresponding psychosis diagnoses, their fixed false beliefs, and most importantly, their treatments. </P>
<P> </P>
<P>These anxiety and depressive comorbidities have long been long overlooked as an understandable hodgepodge of distressing symptoms caused by the pain of psychosis. But these five comorbidities usually precede onset of the psychosis, and their treatment can significantly improve outcome. So, maybe, the causation is the other way around: maybe they are among the underlying contributors to schizophrenia and other psychotic disorders. </P>
<P> </P>
<P>The chapter authors expertly detail the data supporting this innovative approach. They provide fictional case studies, DSM-5 diagnostic criteria, specific interviewing approaches for the five comorbidities in psychosis patients, and improved treatment options. Other chapters explore psychoses related to substance use, medical illness and medical treatment, as well as other factors that contribute to psychotic disorders. </P>
<P> </P>
<P>This first-of-its-kind reference is a valuable clinical, educational, research and training resource for psychiatrists, psychologists, nurses, social workers, neurologists and anyone interested in the care and treatment of someone with a psychotic disorder.</P> <P>A counterintuitive and novel approach to the long-sought goal of subtyping schizophrenia and other psychotic disorders emerges from ongoing research. Five psychosis associated anxiety and depressive subtypes each help define five corresponding psychosis diagnoses, their fixed false beliefs, and most importantly, their treatments. </P>
<P> </P>
<P>These anxiety and depressive comorbidities have long been long overlooked as an understandable hodgepodge of distressing symptoms caused by the pain of psychosis. But these five comorbidities usually precede onset of the psychosis, and their treatment can significantly improve outcome. So, maybe, the causation is the other way around: maybe they are among the underlying contributors to schizophrenia and other psychotic disorders. </P>
<P> </P>
<P>The chapter authors expertly detail the data supporting this innovative approach. They provide fictional case studies, DSM-5 diagnostic criteria, specific interviewing approaches for the five comorbidities in psychosis patients, and improved treatment options. Other chapters explore psychoses related to substance use, medical illness and medical treatment, as well as other factors that contribute to psychotic disorders. </P>
<P> </P>
<P>This first-of-its-kind reference is a valuable clinical, educational, research and training resource for psychiatrists, psychologists, nurses, social workers, neurologists and anyone interested in the care and treatment of someone with a psychotic disorder.</P>00add-to-cart97803236830982020ProfessionalEdited by André Barciela Veras, MD, PhD and Jeffrey P. Kahn, MD20211Book152w x 229h (6.00" x 9.00")Saunders160Dec 3, 2020IN STOCKEdited by <STRONG>André Barciela Veras</STRONG>, MD, PhD, Department of Psychiatry, University of the State of Mato Grosso do Sul, Campo Grande – MS, Brazil and <STRONG>Jeffrey P. Kahn</STRONG>, MD, Weill-Cornell Medical College, New York, New YorkBooks, eBooksBooksNoNoNoNoPlease SelectPlease SelectPlease Select
